IP Verse

Crispr-Based Genome Modification And Regulation - EP3138912B1

PatentPatent Analysis

EP3138912

SIGMA ALDRICH
Application Number
EP16183725A
Filing Date
Dec 5, 2013
Status
Revoked
Aug 26, 2022
Grant Date
Dec 5, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3363902B1
EP2928496B1
EP3360964B1

Bibliography

The patent EP3138912B1 was granted to Sigma Aldrich on Dec 5, 2018 following the initial filing on Dec 5, 2013 under the application number EP16183725A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

POHLMANSep 5, 2019ADMISSIBLE
BASFSep 4, 2019ADMISSIBLE
BAYER BAYERJun 18, 2019ADMISSIBLE
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBFeb 22, 2019ADMISSIBLE
GRUNDJan 30, 2019ADMISSIBLE
SCHLICHDec 6, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents